Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

Delayed Quote. Delayed  - 12/05 03:17:39 pm
33.255 GBp   -2.91%
12/01 VERNALIS PLC : AGM Statement
12/01 VERNALIS : Takes Steps To Drive Demand For Tuzistra, Progress Pipeli..
10/24 VERNALIS : Notice of Annual Report and AGM
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vernalis plc
Researches and develops pharmaceutical products

Vernalis Plc engages in the research, development, and commercialization of pharmaceutical products under the Tuzistra XR brand.

The company was founded by Keith G. McCullagh in 1986 and is headquartered in Winnersh, United Kingdom.

Number of employees : 103 persons.
Sales per Businesses
20152016Delta
GBP (in Million)%GBP (in Million)%
Pharmaceuticals13.26100%---
Research & Development--8.0466.8%-
Commercial--3.9933.2%-
Sales per Regions
20152016Delta
GBP (in Million)%GBP (in Million)%
Rest of Europe10.2577.4%8.1367.6% -20.68%
Rest of the World2.3217.5%2.7322.7% +18%
North America0.6695%1.169.7% +73.69%
United Kingdom0.0160.1%0.0050% -68.75%
Managers
NameAgeSinceTitle
Ian Garland50-Chief Executive Officer & Executive Director
Peter John Fellner, PhD732003Non-Executive Chairman
David MacKney48-Chief Financial Officer & Executive Director
Pascal Borderies, MD-2014Senior Vice President-Medical Affairs
Carol C. Ferguson692003Senior Independent Non-Executive Director
Nigel Sheail502011Independent Non-Executive Director
Ian David Gilham, PhD562015Independent Non-Executive Director
Lisa Amster Schoenberg, MBA492015Non-Executive Director
Kevin Kissane602010Secretary & General Counsel
Mike Wood-2004Research Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 526,352,521 520,625,189 98.9% 0 0.0% 98.9%
Shareholders
NameEquities%
Invesco Asset Management Ltd. 194,441,770 36.9%
Woodford Investment Management LLP 157,226,138 29.9%
GAM London Ltd. 47,861,787 9.09%
Legal & General Investment Management Ltd. 30,642,580 5.82%
Aviva Investors Global Services Ltd. 26,309,928 5.00%
Rothschild Bank AG 12,129,000 2.30%
Majedie Asset Management Ltd. 5,991,000 1.14%
EdenTree Investment Management Ltd. 4,750,000 0.90%
River & Mercantile Asset Management LLP 2,800,000 0.53%
Medical Strategy GmbH 2,769,929 0.53%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
VERNALIS PLC-51.68%229
INCYTE CORPORATION-7.86%19 219
QUINTILES IMS HOLDINGS..6.32%18 225
CELLTRION, INC.--.--%9 953
SEATTLE GENETICS, INC.48.64%9 442
LONZA GROUP AG11.34%9 247
ALKERMES PLC-29.14%8 548
QIAGEN NV-2.75%6 542
UNITED THERAPEUTICS CO..-19.23%5 365
IONIS PHARMACEUTICALS ..-30.57%5 212
ICON PLC-3.15%4 173
BIO-TECHNE CORP17.11%3 932
ALNYLAM PHARMACEUTICAL..-55.83%3 567
CHARLES RIVER LABORATO..-12.90%3 402
INTREXON CORP-6.20%3 353
ACADIA PHARMACEUTICALS..-25.72%3 288
PRA HEALTH SCIENCES IN..14.87%3 228
PAREXEL INTERNATIONAL ..-14.06%3 129
BB BIOTECH AG-8.81%2 906
GALAPAGOS-2.96%2 716
INC RESEARCH HOLDINGS ..0.49%2 614
Sector Biotechnology & Medical Research - NEC
Vernalis plc : Connections
Vernalis Plc
100 Berkshire Place
Wharfedale Road
Winnersh, Berkshire RG41 5RD

Phone : +44.118.938.0000
Fax : +44.118.938.0001
Web : www.vernalis.com
© 2016 People , Fundamentals and Ownership